Biomerica (BMRA) Cost of Revenue (2016 - 2026)
Biomerica's Cost of Revenue history spans 17 years, with the latest figure at $1.0 million for Q1 2026.
- On a quarterly basis, Cost of Revenue rose 216.26% to $1.0 million in Q1 2026 year-over-year; TTM through Feb 2026 was $6.7 million, a 62.04% increase, with the full-year FY2025 number at $4.8 million, changed 0.19% from a year prior.
- Cost of Revenue hit $1.0 million in Q1 2026 for Biomerica, down from $1.2 million in the prior quarter.
- Over the last five years, Cost of Revenue for BMRA hit a ceiling of $6.0 million in Q1 2022 and a floor of $326000.0 in Q1 2025.
- Historically, Cost of Revenue has averaged $1.8 million across 5 years, with a median of $1.2 million in 2024.
- Biggest five-year swings in Cost of Revenue: skyrocketed 349.58% in 2022 and later tumbled 83.45% in 2023.
- Tracing BMRA's Cost of Revenue over 5 years: stood at $1.1 million in 2022, then grew by 9.91% to $1.2 million in 2023, then dropped by 3.46% to $1.2 million in 2024, then fell by 3.34% to $1.2 million in 2025, then dropped by 11.04% to $1.0 million in 2026.
- Business Quant data shows Cost of Revenue for BMRA at $1.0 million in Q1 2026, $1.2 million in Q4 2025, and $956000.0 in Q3 2025.